Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
93.00    0.00 (0.00%)
Bid:
91.00
Ask:
95.00
Spread: 4.00 (4.396%)
Market Cap: £62.39m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Director/PDMR Shareholding

19 Dec 2016 10:42

19 December 2016

ECO Animal Health Group plc ("ECO" or the "Company")

Director/PDMR Shareholding and Notification

The Company was notified on Friday 16 December by the following Directors of the Company of the exercise and subsequent sale of 155,000 options, all at a price of £5.00, at £1.96 per ordinary share of 5 pence each in the Company ("Ordinary Share"), being Ordinary Shares granted as unapproved share options under the Executive Share Option Scheme.

Director Position Holding pre option exercise and share sale Options exercised and then sold (“Sale”) Option cost per Ordinary Share Options held post Sale Ordinary Share holding post Sale %
Brett

Clemo

Executive Director 830,000 100,000 196p 730,000 0.01
Kevin

Stockdale

Finance Director 422,500 50,000 196p 372,500 0.01
Marc

Coulier

PDMR 137.000 5,000 196p 132,000 NIL

Following these transactions, the Company’s issued ordinary share capital consists of 65,347,706 Ordinary Shares. Each Ordinary Share carries one vote. Accordingly, the number of Ordinary Shares with voting rights in issue is 65,347,706.

1. Details of the person discharging managerial responsibilities / person closely associated
a. Name 1. Brett Clemo

2. Kevin Stockdale

3. Marc Coulier

2. Reason for the notification
a. Position/status 1. Executive Director

2. Finance Director

3. PDMR

b. Initial notification

/Amendment

Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. Name ECO Animal Health Group plc
b. LEI 01818170
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each

GB0032036807

b. Nature of the transaction

1. Exercise of 100,000 options under the Executive Share Option Scheme

2. Exercise of 50,000 options under the Executive Share Option Scheme

3. Exercise of 5,000 options under the Executive Share Option Scheme

c. Price(s) and volume(s)

Price(s) Volume(s)

1. 196p 100,000

2. 196p 50,000

3. 196p 5,000

d. Aggregated information

· Aggregated volume

· Price

Price(s) Volume(s)

1. 196p 100,000

2. 226p 50,000

3. 196p 5,000

e. Date of the transaction 2016-12-16
f. Place of the transaction London Stock Exchange (XLON) AIM market
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each

GB0032036807

b. Nature of the transaction 1. Sale of 100,000 shares arising from the exercise of options under the Executive Share Option Scheme

2. Sale of 50,000 shares arising from the exercise of options under the Executive Share Option Scheme

3. Sale of 5,000 shares arising from the exercise of options under the Executive Share Option Scheme

c. Price(s) and volume(s)

Price(s) Volume(s)

1. 500p 100,000

2. 500p 50,000

3. 500p 5,000

d. Aggregated information

· Aggregated volume

· Price

Average price(s) Total volume(s)

1. 500p 100,000

2. 500p 50,000

3. 500p 5,000

e. Date of the transaction 2016-12-16
f. Place of the transaction London Stock Exchange (XLON) AIM market

Enquiries

ECO Animal Health Group plc

Peter Lawrence, Executive Chairman 020 8336 6190

Marc Loomes, CEO 020 8447 8899

Spiro Financial

Anthony Spiro 020 8336 6196

Peel Hunt LLP (Nominated Adviser)

Dan Webster, Adrian Trimmings, George Sellar 020 7418 8900

View source version on businesswire.com: http://www.businesswire.com/news/home/20161219005484/en/

Copyright Business Wire 2016

Date   Source Headline
4th Jun 20267:00 amRNSRenewal of revolving credit facility
14th Apr 20267:00 amRNSAppointment of Head of Business Development
31st Mar 20267:00 amRNSBoard Change
19th Mar 20267:00 amRNSFull Year Trading Update
11th Mar 20267:00 amRNSECOVAXXIN® MG favourable USDA safety assessment
11th Mar 20267:00 amRNSECOVAXXIN®?MG favourable USDA safety assessment
5th Mar 20264:19 pmRNSBlock Listing Return
26th Feb 20267:00 amRNSEU launch plans for ECOVAXXIN® MS
19th Jan 20261:50 pmRNSHolding(s) in Company
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
18th Dec 20257:00 amRNSExercise of Share Options by Director
9th Dec 20255:57 pmRNSHolding(s) in Company
4th Dec 20252:10 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSResults for the six months ended 30 September 2025
20th Nov 20259:47 amRNSReplacement: Notice of Results
20th Nov 20257:00 amRNSNotice of Results
10th Nov 20257:00 amRNSEMA Positive Opinion Received for ECOVAXXIN® MS
1st Oct 20257:00 amRNS-RHead of Global R&D
25th Sep 20253:15 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Trading Update and Notice of Interim Results
1st Sep 20257:00 amRNSAppointment of Joint Broker
29th Aug 20257:00 amRNSShare Awards to Executive Directors
28th Aug 20257:48 amRNSPosting of Annual Report and Notice of AGM
21st Aug 202512:29 pmRNSResult of General Meeting
13th Aug 20257:00 amRNSBlock Listing Return
6th Aug 20255:09 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSHolding(s) in Company
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
14th Jul 20257:00 amRNSResults for the year ended 31 March 2025
8th Jul 20254:10 pmRNSNotice of General Meeting and Notice of Results
2nd May 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Update
13th Mar 20257:00 amRNSR&D Day
3rd Mar 20257:00 amRNSSubmission of Marketing Authorisation Application
24th Feb 20254:08 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSDisposal of non-core assets
18th Feb 20257:00 amRNSBlock listing Interim Review
13th Feb 20257:00 amRNSNotice of R&D Day
31st Jan 20257:00 amRNSBoard Changes
20th Dec 20247:00 amRNSHolding(s) in Company
16th Dec 20247:00 amRNSHolding(s) in Company
2nd Dec 202412:30 pmRNSShare Purchase by Executive Director
28th Nov 20247:00 amRNSResults for the Six Months Ended 30 September 2024
28th Oct 202412:57 pmRNSShare Awards to Executive Directors
22nd Oct 202411:00 amRNSEBT Share Purchase
21st Oct 20247:00 amRNSEBT Share Purchase
14th Oct 202411:07 amRNSEBT Share Purchase
9th Oct 20247:00 amRNSIssue of Equity and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.